Tag: FDA adverse event reporting
The FDA monitors generic drug safety after approval through real-time reporting, manufacturing data, and patient feedback. Learn how adverse events are tracked, what gaps exist, and what’s changing in 2025 to improve detection of quality and effectiveness issues.
Archives
Recent-posts
Best Substitutes for Coumadin: Comparing DOACs, Rivaroxaban, Apixaban & Lifestyle Changes
Jul, 28 2025

Medications